About Matthew Tindall
Form D filings for FlightPath Biosciences from 2020 to 2024 list Matthew Tindall as president and director.
Matthew Tindall first appears on SEC filings in 2020.
Experience
This experience comes from SEC filings. The years are when the filings name Matthew Tindall in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Matthew Tindall works with at each company, as listed on that company's latest Form D.
FlightPath Biosciences, Inc. · Form D/A, Oct 24, 2024
CS
Curtis Scribner
Director
CL
Cristina Larkin
Director